wild-type melanomas have a high mutation load correlating with histological and molecular signatures of UV damage

1. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3010, Australia. 2. Molecular Pathology Research and Development Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3. Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. 4. Translational Research Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. 5. Department of Medicine, St. Vincent’s Hospital, University of Melbourne, Fitzroy, Victoria 3065, Australia.

[1]  R. Scolyer,et al.  Biospecimen banking: The pathway to personalized medicine for patients with cancer , 2013, Journal of surgical oncology.

[2]  D. English,et al.  Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia. , 2013, Journal of the American Academy of Dermatology.

[3]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[4]  A. Sivachenko,et al.  A Landscape of Driver Mutations in Melanoma , 2012, Cell.

[5]  R. Scolyer,et al.  Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Matthew J. Davis,et al.  Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma , 2012, Nature Genetics.

[7]  A. Dobrovic,et al.  Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders , 2012, Haematologica.

[8]  Lauren E Haydu,et al.  Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma , 2012, Clinical Cancer Research.

[9]  Xianqun Fan,et al.  Therapeutic Efficacy by Targeting Correction of Notch1-Induced Aberrants in Uveal Tumors , 2012, PloS one.

[10]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[11]  T. Fennell,et al.  Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.

[12]  K. Dutton-Regester,et al.  A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma , 2012, Molecular Cancer Therapeutics.

[13]  F. Kelleher,et al.  Targeting NRAS in Melanoma , 2012, Cancer journal.

[14]  A. Ashworth,et al.  Whole genome sequencing of matched primary and metastatic acral melanomas. , 2012, Genome research.

[15]  J. Handa,et al.  Notch Signaling Promotes Growth and Invasion in Uveal Melanoma , 2012, Clinical Cancer Research.

[16]  C. V. Jongeneel,et al.  Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma , 2011, Nature Genetics.

[17]  Lee T. Sam,et al.  Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study , 2011, Science Translational Medicine.

[18]  David C Whiteman,et al.  The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin , 2011, Pigment cell & melanoma research.

[19]  C. Tzen,et al.  Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma , 2011, Pigment cell & melanoma research.

[20]  S. Davis,et al.  Exome sequencing identifies GRIN2A as frequently mutated in melanoma , 2011, Nature Genetics.

[21]  J. Tenenbaum,et al.  A Melanoma Molecular Disease Model , 2011, PloS one.

[22]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[23]  D. Schadendorf,et al.  Genetic and morphologic features for melanoma classification , 2010, Pigment cell & melanoma research.

[24]  Li-E. Wang,et al.  Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma , 2010, Clinical Cancer Research.

[25]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[26]  Jimmy Lin,et al.  Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4 , 2009, Nature Genetics.

[27]  Chenwei Wang,et al.  Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma , 2009, Nature Genetics.

[28]  Susan Muller,et al.  KIT Gene Mutations and Copy Number in Melanoma Subtypes , 2008, Clinical Cancer Research.

[29]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[30]  G. Saldanha,et al.  Cutaneous Melanoma Subtypes Show Different BRAF and NRAS Mutation Frequencies , 2006, Clinical Cancer Research.

[31]  M. Trivett,et al.  Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. , 2007, The Journal of investigative dermatology.

[32]  Ajay N. Jain,et al.  Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.

[33]  F. Collins,et al.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients , 1992, Nature.

[34]  K. Flaherty,et al.  Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort. , 2012, European journal of cancer.

[35]  M. Weinstock,et al.  The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. , 2012, Archives of dermatology.

[36]  Gurpreet W. Tang,et al.  COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer , 2010, Nucleic Acids Res..

[37]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..

[38]  Jane Fridlyand,et al.  Academic Editor: Jonathan Rees, University of Edinburgh, United Kingdom , 2007 .

[39]  J. Stockman,et al.  Distinct Sets of Genetic Alterations in Melanoma , 2007 .

[40]  P. Meltzer,et al.  High frequency of BRAF mutations in nevi , 2003, Nature Genetics.